Skip to main content

🔴 This is an archived resource.

This resource has not been reviewed within the last three years to reflect up to date clinical guidelines and should be referenced with care.


Evaluation of the efficacy and safety of endoscopically achieved proximal intestinal exclusion as an adjunct to glucagon-like peptide-1  therapy in Diabesity: REVISE-DIABESITY randomised clinical trial.



P. Sen Gupta, B. McGowan, R. Drummond, S. Amiel, B. Ryder.